Non-Current Liabilities
Long-Term Debt
Gilead Sciences Long-Term Debt decreased by 5.7% to $20.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.8%, from $22.15B to $20.86B. Over 5 years (FY 2020 to FY 2025), Long-Term Debt shows a downward trend with a -5.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
High levels increase financial risk but may be necessary for growth; decreasing levels signal deleveraging and improved financial health.
Detailed definition
Long-term debt includes all interest-bearing financial obligations with maturities extending beyond one year, such as bo...
Peer comparison
Standard leverage metric; compared across peers using debt-to-equity or debt-to-EBITDA ratios.
Metric ID:
long_term_debtHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.91B | $25.18B | $25.18B | $25.18B | $25.2B | $22.95B | $22.96B | $22.96B | $21.21B | $23.19B | $23.19B | $21.53B | $21.54B | $21.44B | $24.9B | $22.15B | $22.14B | $22.14B | $22.13B | $20.86B |
| QoQ Change | — | -9.8% | +0.0% | +0.0% | +0.0% | -8.9% | +0.0% | -0.0% | -7.6% | +9.3% | +0.0% | -7.2% | +0.1% | -0.5% | +16.1% | -11.0% | -0.0% | -0.0% | -0.0% | -5.7% |
| YoY Change | — | — | — | — | -9.7% | -8.8% | -8.8% | -8.8% | -15.8% | +1.0% | +1.0% | -6.2% | +1.6% | -7.6% | +7.4% | +2.9% | +2.8% | +3.3% | -11.1% | -5.8% |
Range$20.86B – $27.91B
CAGR-5.9%
Avg YoY Growth-3.9%
Median YoY Growth-6.0%
Current Streak5 quarters decline
Long-Term Debt at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's long-term debt?
- Gilead Sciences (GILD) reported long-term debt of $20.86B in Q1 2026.
- How has Gilead Sciences's long-term debt changed year-over-year?
- Gilead Sciences's long-term debt decreased by 5.8% year-over-year, from $22.15B to $20.86B.
- What is the long-term trend for Gilead Sciences's long-term debt?
- Over 5 years (2020 to 2025), Gilead Sciences's long-term debt has grown at a -5.0% compound annual growth rate (CAGR), from $28.65B to $22.13B.
- What does long-term debt mean?
- Total debt obligations that are not due for at least one year.